XTX Topco’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.7K | Buy |
+24,234
| New | +$64.7K | ﹤0.01% | 1970 |
|
|
2024
Q4 | – | Sell |
-1,153
| Closed | -$21.4K | – | 3056 |
|
|
2024
Q3 | $21.4K | Sell |
1,153
-901
| -44% | -$16.8K | ﹤0.01% | 1829 |
|
|
2024
Q2 | $34.2K | Buy |
2,054
+34
| +2% | +$566 | ﹤0.01% | 1549 |
|
|
2024
Q1 | $35.1K | Sell |
2,020
-363
| -15% | -$6.3K | ﹤0.01% | 1531 |
|
|
2023
Q4 | $37.3K | Sell |
2,383
-1,271
| -35% | -$19.9K | 0.01% | 1283 |
|
|
2023
Q3 | $181K | Buy |
+3,654
| New | +$181K | 0.03% | 1050 |
|
|
2023
Q2 | – | Sell |
-848
| Closed | -$76.9K | – | 1923 |
|
|
2023
Q1 | $76.9K | Sell |
848
-1,475
| -63% | -$134K | 0.02% | 1128 |
|
|
2022
Q4 | $274K | Buy |
2,323
+1,627
| +234% | +$192K | 0.06% | 646 |
|
|
2022
Q3 | $126K | Buy |
696
+139
| +25% | +$25.2K | 0.03% | 902 |
|
|
2022
Q2 | $50K | Buy |
+557
| New | +$50K | 0.02% | 744 |
|